NCT07409584 Mental Health and Suicidality in Glioblastoma Patients in Germany
| NCT ID | NCT07409584 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Essen |
| Condition | Glioblastoma (GBM) |
| Study Type | OBSERVATIONAL |
| Enrollment | 176 participants |
| Start Date | 2026-03-18 |
| Primary Completion | 2027-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 176 participants in total. It began in 2026-03-18 with a primary completion date of 2027-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to use standardized questionnaires to systematically record influencing factors or predictors for suicidal behavior in glioblastoma patients, particularly with regard to existing depression and anxiety symptoms.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of glioblastoma, IDH wild-type (CNS WHO classification of 2021) * Age ≥ 18 years Exclusion Criteria: * Participants with clinically significant aphasia or language barrier as assessed by the investigator * History of other malignant tumors * Known tumor predisposition syndrome (e.g., Li-Fraumeni syndrome, Cowden syndrome, etc.)
Contact & Investigator
Sied Kebir, PD Dr. med.
PRINCIPAL INVESTIGATOR
University Hospital, Essen
Frequently Asked Questions
Who can join the NCT07409584 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Glioblastoma (GBM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07409584 currently recruiting?
Yes, NCT07409584 is actively recruiting participants. Contact the research team at christoph.oster@uk-essen.de for enrollment information.
Where is the NCT07409584 trial being conducted?
This trial is being conducted at Berlin, Germany, Bochum, Germany, Essen, Germany, Hamburg, Germany and 2 additional locations.
Who is sponsoring the NCT07409584 clinical trial?
NCT07409584 is sponsored by University Hospital, Essen. The principal investigator is Sied Kebir, PD Dr. med. at University Hospital, Essen. The trial plans to enroll 176 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.